ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO786

B Cells Unhinged: Concurrent PR3+ ANCA-Associated Vasculitis and Diffuse Large B Cell Lymphoma Treated Effectively

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Sachsenmeier, Eliot, NYU Langone Hospital - Long Island, Mineola, New York, United States
  • Silverio De Castro, Yinelka G., NYU Langone Hospital - Long Island, Mineola, New York, United States
  • Drakakis, James, NYU Langone Hospital - Long Island, Mineola, New York, United States
  • Khatri, Minesh, NYU Langone Hospital - Long Island, Mineola, New York, United States
Introduction

We present a case of PR3+ ANCA vasculitis diagnosed simultaneously with diffuse large B-cell lymphoma (DLBCL). Both improved after rituximab and chemotherapy. This appears to be the third case of DLBCL-associated ANCA vasculitis described in the literature. The mechanisms of this association and implications for therapy warrant future investigation.

Case Description

71-year-old man with hypermetabolic lung and left tonsillar masses on outpatient PET-CT presented for fatigue, anorexia, and weight loss. Laboratory testing showed an elevated creatinine of 5.87 mg/dL. Serologic workup revealed an elevated proteinase-3 level of 183. CT chest confirmed a spiculated right upper lobe nodule measuring 3.1 cm with architectural distortion. He received three dialysis treatments and was started on pulse dose steroids. He underwent renal and lung biopsy, showing diffuse necrotizing and crescentic pauci-immune glomerulonephritis (Fig. 1), and pulmonary parenchyma effaced by sheets of large, atypical B-lymphocytes compatible with DLBCL. Two months later, after daily prednisone, 4 doses of weekly rituximab, and 2 cycles of Pola-CHP, his creatinine was 1.31 mg/dL. Repeat PET-CT showed complete resolution of the hypermetabolic left tonsillar mass and near complete resolution of the right upper lobe mass.

Discussion

While uncommon, malignancy is diagnosed more frequently in patients with ANCA vasculitis, especially granulomatosis with polyangiitis (GPA). The most common cancers diagnosed include bladder cancer, non-melanoma skin cancer, leukemia, and lymphoma. Association with the latter two may relate to overexpression of PR3 in response to granulocyte colony stimulating factor. The overexpression of PR3 may trigger an immune response that harms normal and malignant tissue. Alternatively, PR3-specific B cell clones may proliferate to become lymphoma. Our patient’s improvement with combination therapy may support a common cause.

Fig. 1